908 Devices (MASS) Depreciation & Amortization (CF) (2020 - 2026)
908 Devices (MASS) reported Depreciation & Amortization (CF) of $1.1 million for Q1 2026, down 11.77% year-over-year from $1.3 million in Q1 2025, and up 2.52% quarter-over-quarter from $1.1 million in Q4 2025.
908 Devices (MASS) Depreciation & Amortization (CF) (2020 - 2026) Analysis & Trends
908 Devices (MASS) has 7 years of Depreciation & Amortization (CF) data on file, last reported at $1.1 million in Q1 2026.
- Depreciation & Amortization (CF) for Q1 2026 came in at $1.1 million, down 11.77% year-over-year; the trailing twelve-month figure through Mar 2026 was $4.3 million (down 7.15% YoY), and the FY2025 annual result was $4.5 million, down 4.63% from the prior year.
- Depreciation & Amortization (CF) climbed to $1.1 million in Q1 2026 per MASS's latest filing, from $1.1 million in the prior quarter.
- Over five years, Depreciation & Amortization (CF) peaked at $1.4 million in Q4 2024 and troughed at $267000.0 in Q1 2022.
- A 5-year average of $840235.3 and a median of $740000.0 in 2023 frame the typical range for Depreciation & Amortization (CF).
- The sharpest annual moves came in 2023 and 2024: Depreciation & Amortization (CF) retreated 29.81% in 2023, then soared 254.81% in 2024.
- A 5-year view of Depreciation & Amortization (CF) shows it stood at $577000.0 in 2022, then decreased by 29.81% to $405000.0 in 2023, then soared by 254.81% to $1.4 million in 2024, then dropped by 22.69% to $1.1 million in 2025, then gained by 2.52% to $1.1 million in 2026.
- Business Quant data shows MASS's Depreciation & Amortization (CF) at $1.1 million in Q1 2026, $1.1 million in Q4 2025, and $1.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | 381.00 Mn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 120.00 Mn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | 749.00 Mn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 351.00 Mn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | 40.90 Mn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 78.00 Mn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | 67.10 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | 123.40 Mn |
| 10 | 908 Devices | 304.12 Mn | 192.38 Mn | 6.88 Mn | 1.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.14 Mn |
| Mar 31, 2026 | 1.14 Mn |
| Dec 31, 2025 | 1.11 Mn |
| Dec 31, 2025 | 1.11 Mn |
| Sep 30, 2025 | 1.09 Mn |
| Sep 30, 2025 | 1.09 Mn |
| Jun 30, 2025 | 972,000.00 |
| Jun 30, 2025 | 972,000.00 |
| Mar 31, 2025 | 1.29 Mn |
| Mar 31, 2025 | 1.29 Mn |
| Dec 31, 2024 | 1.44 Mn |
| Dec 31, 2024 | 1.44 Mn |
| Sep 30, 2024 | 1.41 Mn |
| Sep 30, 2024 | 1.41 Mn |
| Jun 30, 2024 | 504,000.00 |
| Jun 30, 2024 | 504,000.00 |
| Mar 31, 2024 | 1.33 Mn |
| Mar 31, 2024 | 1.33 Mn |
| Dec 31, 2023 | 405,000.00 |
| Dec 31, 2023 | 405,000.00 |